Navigation Links
Ambulatory Services of America, Inc. Announces Joint Venture with Gulf Coast Cancer Centers
Date:1/7/2009

NASHVILLE, Tenn., Jan. 7 /PRNewswire/ -- Ambulatory Services of America, Inc. announced the formation of ROSA of South Alabama, LLC, its seventh radiation oncology joint venture. ROSA of South Alabama is a joint venture among Gulf Coast Cancer Center - Gulf Shores, P.C., Monroeville Radiation - Oncology, P.C., and South Alabama Radiation Oncology, P.C., and ASA's subsidiary, Radiation Oncology Services of America, Inc. ROSA of South Alabama will own and operate four radiation oncology facilities in Gulf Shores, Brewton, Foley and Monroeville, Alabama.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071218/CLTU087LOGO )

ROSA of South Alabama will offer state-of-the-art cancer treatment services, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic body radiation therapy (SBRT) in the facilities. The joint venture expects to build on Gulf Coast Cancer Centers' legacy of providing high-quality cancer care to the residents and visitors to the south Alabama region. The physicians currently serving patients at each facility will continue to provide physician services to patients being treated at the facilities. William Hixson, M.D. will serve as medical director for each of the facilities.

Dr. Hixson said, "When considering a partnership, we looked for a strong, growing company that not only brings business expertise to the table but, most importantly, also shares our passion for patient care. We look forward to working with ASA and ROSA as we continue our mission of providing superior care and service to the growing number of cancer patients in the Gulf Coast area."

Timothy Martin, President and Chief Executive Officer of ASA, said, "We are pleased to welcome the physicians and staff of Gulf Coast Cancer Centers to the ASA family. Dr. Hixson and his team are recognized in the industry as providers of high-quality cancer care through state-of-the-art technology, treatments and procedures. We look forward to working with them to continue to provide excellent service to cancer patients in the Gulf Coast region."

Ambulatory Services of America, headquartered in Brentwood, Tennessee, is a diversified health care services company that provides alternative site services in partnership with physicians. ASA, through its primary subsidiaries Radiation Oncology Services of America, Inc. and Innovative Dialysis Systems, Inc. owns, operates and manages facilities providing radiation oncology services and dialysis services. After the formation of ROSA of South Alabama, ASA will own interests in and operate 17 radiation oncology centers and 44 dialysis centers in eleven states and the territory of Guam.


'/>"/>
SOURCE Ambulatory Services of America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS
2. B. Braun Medical Inc. Launches Ambulatory Surgical Center Website
3. Greenway Medical Technologies Leads Ambulatory Interoperability Exchange
4. Ambulatory Services of America, Inc. Announces the Acquisition of Dialysis Operations in St. Louis, Missouri
5. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Chicago-Area Radiation Oncology Facility
6. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Radiation Oncology Facility in Dallas, Texas
7. Ambulatory Services of America, Inc. Announces Investment by Lindsay Goldberg
8. Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP
9. Reproductive Science Center of New England Receives Ambulatory Health Care Accreditation
10. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
11. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... ... appointment of Mike Finnegan to the position of Executive Vice President, Sales and ... in healthcare technology, telehealth and medical device sales leadership. He has received industry ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... many of the health care industry’s hospitals and provider groups, has announced that ... for select customers. Parasail Health is a San Francisco health-finance startup that has ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article ... reach a staggering $6.81 billion by the year 2024 according to a new report. ... rate than those made from titanium. Los Angeles area clinic Beverly Hills Periodontics & ...
(Date:6/27/2017)... ... June 27, 2017 , ... Atmosera , ... Atmosera Managed Azure Services . The trusted, transparent, and secure solution for the ... growing customer base. Atmosera’s next generation services include integrated capabilities for public, private, ...
(Date:6/27/2017)... ... June 27, 2017 , ... Today, June 27th is ... PTSD. Yet less than 20% will receive adequate care due to lack of effective ... receive any care at all. And left untreated, veterans are at an increased risk ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... -- Exactly 50 years ago today, the Monterey Pop Festival opened ... the San Francisco "Summer of Love."  To celebrate the anniversary, ... in strategic market research portals that it will begin delivering ... Northern Light,s "Summer of Love (For Our Customers)."  ... ...
(Date:6/14/2017)... , June 14, 2017  In 2016, Embodied ... Startups pitch competition and came away with $25,000 ... is described by Forbes as "entering the life of ... Association as teaching "empathy to medical professionals in an ... was recently named a finalist for the Department of ...
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
Breaking Medicine Technology: